Skip to main content
Top
Published in: Netherlands Heart Journal 4/2017

Open Access 01-04-2017 | Original Article

Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome

Authors: N. P. G. Hoedemaker, M. E. ten Haaf, J. C. Maas, P. Damman, Y. Appelman, J. G. P. Tijssen, R. J. de Winter, A. W. J. van ‘t Hof

Published in: Netherlands Heart Journal | Issue 4/2017

Login to get access

Abstract

Background

Clinical registries provide information on the process of care and patient outcomes, with the potential to improve the quality of patient care. A large Dutch national acute coronary syndrome (ACS) registry is currently lacking. Recently, we initiated the National Cardiovascular Database Registry (NCDR) for ACS in the Netherlands. The purpose of this study was to assess the NCDR ACS registry on feasibility and data completeness during a pilot phase of four snapshot weeks.

Methods

Between 2013 and 2015, we invited all hospitals in the Netherlands to record a predefined dataset for every patient that was admitted to their hospital with ST-segment elevation myocardial infarction (STEMI). Data were entered in an online case report form. All patient-specific data were encrypted to ensure privacy.

Results

A total of 392 patients were registered in 35 centres. The mean age of the patients was 64 years (SD 13); 8% of patients presented with signs of cardiogenic shock and 11% with an out-of-hospital cardiac arrest. The median time from first medical contact to percutaneous coronary intervention (PCI) was 75 min (IQR 51–108) and this was significantly longer for patients who presented at a non-PCI centre or to a primary care physician. In-hospital and 30-day mortality rates were 5.2% and 7.8%, respectively. The amount of completeness varied, with improved completeness over time.

Conclusion

This report shows that a Dutch ACS registry is feasible with respect to STEMI patients. Data completeness, however, was suboptimal. Improved data completeness is warranted for the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fox KA, Steg PG, Eagle KA. et al. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006. JAMA. 2007;297(17):1892–900. Fox KA, Steg PG, Eagle KA. et al. Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006. JAMA. 2007;297(17):1892–900.
2.
go back to reference Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–65.CrossRefPubMed Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362:2155–65.CrossRefPubMed
3.
go back to reference Zeymer U, Heuer H, Schwimmbeck P, et al. Guideline-adherent therapy in patients with acute coronary syndromes. Epicor Regist Ger Herz. 2015;40(Suppl 1):27–35. Zeymer U, Heuer H, Schwimmbeck P, et al. Guideline-adherent therapy in patients with acute coronary syndromes. Epicor Regist Ger Herz. 2015;40(Suppl 1):27–35.
4.
go back to reference Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart. 2010;96:917–21.CrossRefPubMed Radovanovic D, Erne P. AMIS Plus: Swiss registry of acute coronary syndrome. Heart. 2010;96:917–21.CrossRefPubMed
5.
go back to reference Polonski L, Gasior M, Gierlotka M, et al. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol. 2007;65:861–72, discussion 73–4.PubMed Polonski L, Gasior M, Gierlotka M, et al. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiol Pol. 2007;65:861–72, discussion 73–4.PubMed
6.
go back to reference Hanssen M, Cottin Y, Khalife K, et al. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart. 2012;98:699–705.CrossRefPubMedPubMedCentral Hanssen M, Cottin Y, Khalife K, et al. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart. 2012;98:699–705.CrossRefPubMedPubMedCentral
8.
go back to reference Moussa I, Hermann A, Messenger JC, et al. The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention. Heart. 2013;99:297–303.CrossRefPubMed Moussa I, Hermann A, Messenger JC, et al. The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention. Heart. 2013;99:297–303.CrossRefPubMed
9.
go back to reference Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96:1617–21.CrossRefPubMed Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96:1617–21.CrossRefPubMed
10.
go back to reference Schulz S, Richardt G, Laugwitz KL, et al. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2014;35:2285–94.CrossRefPubMed Schulz S, Richardt G, Laugwitz KL, et al. Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. Eur Heart J. 2014;35:2285–94.CrossRefPubMed
11.
go back to reference Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.CrossRefPubMed Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.CrossRefPubMed
12.
go back to reference Montalescot G, van ’t Hof AW, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371:1016–27.CrossRefPubMed Montalescot G, van ’t Hof AW, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371:1016–27.CrossRefPubMed
13.
go back to reference Steg PG, van ’t Hof A, Hamm CW, et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013;369:2207–17.CrossRefPubMed Steg PG, van ’t Hof A, Hamm CW, et al. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013;369:2207–17.CrossRefPubMed
14.
go back to reference Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation myocardial infarction vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Euro Heart J. 2005;26(1):18–26.CrossRef Terkelsen CJ, Lassen JF, Nørgaard BL, et al. Mortality rates in patients with ST-elevation myocardial infarction vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort. Euro Heart J. 2005;26(1):18–26.CrossRef
15.
go back to reference Puymirat E, Battler A, Birkhead J, et al. Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries. Eur Heart J Acute Cardiovasc Care. 2013;2:359–70.CrossRefPubMedPubMedCentral Puymirat E, Battler A, Birkhead J, et al. Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries. Eur Heart J Acute Cardiovasc Care. 2013;2:359–70.CrossRefPubMedPubMedCentral
16.
go back to reference Bernat I, Horak D, Stasek J, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63:964–72.CrossRefPubMed Bernat I, Horak D, Stasek J, et al. ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial. J Am Coll Cardiol. 2014;63:964–72.CrossRefPubMed
17.
go back to reference Jolly SS, Cairns JA, Yusuf S, et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1‑year follow-up of the prospective randomised TOTAL trial. Lancet. 2016;387:127–35.CrossRefPubMed Jolly SS, Cairns JA, Yusuf S, et al. Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1‑year follow-up of the prospective randomised TOTAL trial. Lancet. 2016;387:127–35.CrossRefPubMed
18.
go back to reference Karrowni W, Vyas A, Giacomino B, et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;6:814–23.CrossRefPubMed Karrowni W, Vyas A, Giacomino B, et al. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2013;6:814–23.CrossRefPubMed
19.
go back to reference Lagerqvist B, Frobert O, Olivecrona GK, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014;371:1111–20.CrossRefPubMed Lagerqvist B, Frobert O, Olivecrona GK, et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med. 2014;371:1111–20.CrossRefPubMed
20.
go back to reference Mehta SR, Jolly SS, Cairns J, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60:2490–9.CrossRefPubMed Mehta SR, Jolly SS, Cairns J, et al. Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation. J Am Coll Cardiol. 2012;60:2490–9.CrossRefPubMed
21.
go back to reference Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677–84.CrossRefPubMed Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677–84.CrossRefPubMed
22.
go back to reference Frobert O, James SK. Thrombus aspiration during myocardial infarction. N Engl J Med. 2014;370:675–6.PubMed Frobert O, James SK. Thrombus aspiration during myocardial infarction. N Engl J Med. 2014;370:675–6.PubMed
23.
go back to reference McNamara RL, Chung SC, Jernberg T, et al. International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries. Int J Cardiol. 2014;175:240–7.CrossRefPubMedPubMedCentral McNamara RL, Chung SC, Jernberg T, et al. International comparisons of the management of patients with non-ST segment elevation acute myocardial infarction in the United Kingdom, Sweden, and the United States: The MINAP/NICOR, SWEDEHEART/RIKS-HIA, and ACTION Registry-GWTG/NCDR registries. Int J Cardiol. 2014;175:240–7.CrossRefPubMedPubMedCentral
24.
go back to reference Chung SC, Gedeborg R, Nicholas O, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383:1305–12.CrossRefPubMedPubMedCentral Chung SC, Gedeborg R, Nicholas O, et al. Acute myocardial infarction: a comparison of short-term survival in national outcome registries in Sweden and the UK. Lancet. 2014;383:1305–12.CrossRefPubMedPubMedCentral
25.
go back to reference Verweij LM, Tra J, Engel J, et al. Data quality issues impede comparability of hospital treatment delay performance indicators. Neth Heart J. 2015;23:420–7.CrossRefPubMedPubMedCentral Verweij LM, Tra J, Engel J, et al. Data quality issues impede comparability of hospital treatment delay performance indicators. Neth Heart J. 2015;23:420–7.CrossRefPubMedPubMedCentral
26.
go back to reference Verheugt FW. Trials, registries and guidelines for non-ST-elevation acute coronary syndromes. Neth Heart J. 2014;22:52–4.CrossRefPubMed Verheugt FW. Trials, registries and guidelines for non-ST-elevation acute coronary syndromes. Neth Heart J. 2014;22:52–4.CrossRefPubMed
27.
go back to reference Badings EA, Remkes WS, Dambrink JH, et al. Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres : Sub-group analysis of the ELISA-3 trial. Neth Heart J. 2016;24:181–7.CrossRefPubMedPubMedCentral Badings EA, Remkes WS, Dambrink JH, et al. Timing of intervention in high-risk non-ST-elevation acute coronary syndromes in PCI versus non-PCI centres : Sub-group analysis of the ELISA-3 trial. Neth Heart J. 2016;24:181–7.CrossRefPubMedPubMedCentral
28.
go back to reference Oosterwerff EF, Fagel ND, Slagboom T, et al. Impact of percutaneous coronary intervention timing on 5‑year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer. Neth Heart J. 2016;24:173–80.CrossRefPubMedPubMedCentral Oosterwerff EF, Fagel ND, Slagboom T, et al. Impact of percutaneous coronary intervention timing on 5‑year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer. Neth Heart J. 2016;24:173–80.CrossRefPubMedPubMedCentral
Metadata
Title
Practice of ST-segment elevation myocardial infarction care in the Netherlands during four snapshot weeks with the National Cardiovascular Database Registry for Acute Coronary Syndrome
Authors
N. P. G. Hoedemaker
M. E. ten Haaf
J. C. Maas
P. Damman
Y. Appelman
J. G. P. Tijssen
R. J. de Winter
A. W. J. van ‘t Hof
Publication date
01-04-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 4/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-017-0947-6

Other articles of this Issue 4/2017

Netherlands Heart Journal 4/2017 Go to the issue